CONSOLIDATED BALANCE SHEET (Unaudited) (USD $) In Millions, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Current Assets
Cash and cash equivalents	$ 17,360	$ 13,531
Short-term investments	757	1,441
Accounts receivable (net of allowance for doubtful accounts of $163 in 2012 and $131 in 2011)	7,952	8,261
Inventories (excludes inventories of $1,446 in 2012 and $1,379 in 2011 classified in Other assets - see Note 6)	6,731	6,254
Deferred income taxes and other current assets	3,429	3,694
Total current assets	36,229	33,181
Investments	5,560	3,458
Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,475 in 2012 and $16,176 in 2011	15,884	16,297
Goodwill	12,168	12,155
Other Intangibles, Net	30,325	34,302
Other Assets	6,135	5,735
Total Assets	106,301	105,128
Current Liabilities
Loans payable and current portion of long-term debt	2,029	1,990
Trade accounts payable	1,804	2,023
Accrued and other current liabilities	8,923	10,170
Income taxes payable	1,512	781
Dividends payable	1,315	1,281
Total current liabilities	15,583	16,245
Long-Term Debt	17,571	15,525
Deferred Income Taxes and Noncurrent Liabilities	14,935	16,415
Merck & Co., Inc. Stockholders' Equity
Common stock, $0.50 par value, Authorized - 6,500,000,000 shares, Issued - 3,577,103,522 shares in 2012 and 2011	1,788	1,788
Other paid-in capital	40,471	40,663
Retained earnings	40,390	38,990
Accumulated other comprehensive loss	(3,040)	(3,132)
Stockholders' equity before deduction for treasury stock	79,609	78,309
Less treasury stock, at cost: 532,699,267 shares in 2012 and 536,109,713 shares in 2011	23,862	23,792
Total Merck & Co., Inc. stockholders' equity	55,747	54,517
Noncontrolling Interests	2,465	2,426
Total equity	58,212	56,943
Total Liabilities and Stockholders' Equity	$ 106,301	$ 105,128